Menu

Wolfson Institute of Preventive Medicine

Search - ZOO
Search - K2
Search - Categories
Search - Contacts
Search - Content
Search - Newsfeeds
Search - Weblinks

14 December 2015

Drug provides another treatment option for an early form of breast cancer

Ellie Stewart, Posted in General News, In the Press, Publications

Drug provides another treatment option for an early form of breast cancer
The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial led by Queen Mary University of London (QMUL). The results of the IBIS-II DCIS trial show that anastrozole is as effective as tamoxifen for this type of breast cancer and could offer a new treatment option for post-menopausal women.

04 June 2015

Attending breast cancer screening reduces risk of death by 40 per cent

Ellie Stewart, Posted in General News, In the Press, Publications

Attending breast cancer screening reduces risk of death by 40 per cent

Women aged 50-69 years who attend mammography screening reduce their risk of dying from breast cancer by 40 per cent compared to women who are not screened – according to a major international review of the latest evidence on breast cancer screening.

23 March 2015

Daily aspirin can reduce cancer risk

Ellie Stewart, Posted in General News, In the Press

Daily aspirin can reduce cancer risk

Professor Jack Cuzick debates the merits of general aspirin use to reduce cancer risk, saying the benefit far outweighs the risks in an article published in the Wall Street Journal.

02 March 2015

Trial of HPV vaccine completed: more effective cancer prevention

, Posted in General News, In the Press, Publications

Trial of HPV vaccine completed: more effective cancer prevention

A new HPV (human papilloma virus) vaccine that protects against 9 types of the virus – 7 of which cause most cases of cervical cancer – has now been fully tested in a trial co-organised by Professor Jack Cuzick.

The new vaccine offers significantly greater protection than the current vaccine, which protects against only two cancer-causing types of HPV.

Return to top